表观遗传轨迹与抗CCP抗体阳性个体临床类风湿关节炎发生的关联:TIP-RA研究
该研究在抗CCP3阳性个体中比较最终发展为RA者(转换者)与保持无症状者(非转换者)的DNA甲基化差异。结果显示转换者基线甲基化已区别于非转换者,且随时间进行性重塑,机器学习模型可准确分类未来转换者。
要点
- 抗CCP3阳性者基线DNA甲基化可区分未来是否发展为RA。
- 转换者甲基化进行性重塑,形成通向早期RA的「RA甲基化轨迹」。
- B细胞中NOTCH信号与DNA修复通路异常富集。
核心结论
- DNA甲基化在抗CCP3阳性无症状个体向RA进展过程中持续动态重塑,而在非转换者与对照中相对稳定。
- 从高危到临床关节炎的表观遗传重塑揭示了致病通路,并提供可能用于预后检测和预防干预的生物标志物。
研究设计与样本
- 在基线及最长五年纵向采集外周血单个核细胞,分选CD4记忆T细胞、初始T细胞和B细胞进行全基因组DNA甲基化定量。
- 纳入抗CCP3阳性转换者(n = 21)、抗CCP3阳性非转换者(n = 50)、抗CCP3阴性对照(n = 69)以及早期RA患者(n = 29)。
- 识别差异甲基化位点(DMLs)并进行通路富集分析,采用机器学习算法评估单个CpG位点对未来RA发病的预测价值。
主要发现
- 基线时DMLs可清晰区分转换者与非转换者及早期RA患者。
- 在差异甲基化基因相关通路中,B细胞中异常NOTCH信号和DNA修复通路富集尤为突出。
- 纵向观察中,对照和非转换者甲基化组保持稳定,而转换者进行性重塑,追踪出通向早期RA甲基化组的「RA甲基化轨迹」,涉及调控元件。
- 纳入顶级CpG预测因子的机器学习模型能准确分类未来转换者。
临床怎么用
- DNA甲基化特征可能作为抗CCP3阳性无症状个体的预后检测工具,辅助识别即将进展为RA者。
- 表观遗传重塑涉及的NOTCH信号和DNA修复通路为临床前RA的预防干预提供了潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The presence of anti-citrullinated protein antibodies in the absence of clinical inflammatory arthritis identifies individuals at risk for rheumatoid arthritis (RA). We examined whether epigenetic remodeling of DNA methylation distinguishes those who ultimately develop RA ("converters") from individuals who remain asymptomatic ("nonconverters"). METHODS: Genome-wide DNA methylation was quantified in peripheral blood mononuclear cells separated into CD4 T memory and naive cells and B cells collected at baseline and longitudinally over up to five years from converters who were anti-CCP3 positive (n = 21), nonconverters who were anti-CCP3 positive (n = 50), and controls who were anti-CCP3 negative (n = 69), as well as patients with early RA (n = 29). Differentially methylated loci (DMLs) were identified, followed by pathway enrichment analysis. Machine-learning algorithms assessed the predictive value of individual CpG sites for future RA onset. RESULTS: At baseline, DMLs clearly separated converters from nonconverters and patients with early RA. Among the pathways associated with differentially methylated genes, enrichment of aberrant NOTCH signaling and DNA repair pathways was particularly prominent in B cells. Longitudinally, methylomes remained stable in controls and nonconverters but underwent progressive remodeling in converters, tracing a "RA methylome trajectory" toward the early RA methylome involving regulatory elements. Machine-learning models incorporating top CpG predictors accurately classified future converters with RA. CONCLUSION: DNA methylation is a dynamic process that continuously remodels in individuals who were asymptomatic and anti-CCP3 positive as they progress to disease, whereas it remained relatively stable in nonconverters and controls. Progressive epigenetic remodeling during the trajectory from at risk to clinical arthritis highlights pathogenic pathways and yields biomarkers that may inform prognostic testing and preventive intervention in preclinical RA.
引用
- Prideaux EB, Boyle DL, Choi E, et al. Association of Epigenetic Trajectory With Development of Clinical Rheumatoid Arthritis in Individuals With Anti-Citrullinated Protein Antibody Positivity: Targeting Immune Responses for Prevention of Rheumatoid Arthritis (TIP-RA). Arthritis Rheumatol. 2026. PMID: 42021528. doi:10.1002/art.70193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。